Zika Virus Therapeutics Market: Current Analysis and Forecast (2023-2030)

Report Description

The Global Zika Virus Therapeutics Market is expected to grow at a significant rate of around 5.1% during the forecast period. The Zika virus was first identified in 1947 in Uganda’s Zika Forest. Initially considered a mild concern, its potential complications, particularly its link to birth defects like microcephaly, drew global attention in 2015-2016. Transmitting primarily through Aedes mosquitoes, it spread rapidly across the Americas and raised public health alarms due to its impact on pregnant women and their babies. There has been a significant rise in the market due to rising investments in healthcare departments as well as government awareness programs regarding mosquito-borne diseases. These diseases have increased significantly in recent years and are even more incurable in the elderly population which has been rising consequently over years, which are the key factors that are creating opportunities for the market. For instance, according to the U.S. Department of Health & Human Services in 2021, about 1 in 20 adults aged 20 and older had CAD (about 5%).

GET A REPORT SAMPLE

Bharat Biotech; GeneOne Life Science; GSK plc.; Hawaii Biotech Inc.; Leidos; INOVIO Pharmaceuticals; LUMOS PHARMA; Cytiva; Takeda Pharmaceutical Company Limited; Cerus Corporation are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report

“Amongst vaccine type, live-attenuated vaccine category to witness higher CAGR during the forecast period”

Based on vaccine type, the market is segmented into inactivated vaccine, subunit vaccine, live-attenuated vaccine, and others. The live-attenuated vaccine segment is expected to grow with a high CAGR during the forecast period. Live-attenuated vaccines contain weakened forms of the virus or bacteria they protect against. They stimulate a strong immune response without causing the disease itself. Examples include the measles, mumps, rubella (MMR) vaccine and the oral polio vaccine (OPV). Thus, live-attenuated vaccine are expected to witness a higher CAGR during the forecast period.

“Amongst end users, hospitals held a significant share of the market in 2022”

Based on end use, the market is segmented into hospitals, clinics, and others. The hospitals held a significant share of the market in 2022. Hospitals serve as primary healthcare institutions where patients receive diagnosis, treatment, and ongoing care. They play a pivotal role in patient management by providing state-of-the-art medical facilities, specialized expertise, and a multidisciplinary approach to patient care. The hospitals offer treatment to many patients, allowing them to capitalize on economies of scale and offer more efficient and cost-effective services. Financial incentives from health insurance companies are also a major factor, as these can reduce the cost of treatment and make it more affordable for patients. For instance, according to the American Hospital Association in 2023, there are in total of 6,129 hospitals in the U.S with 919,649 staffed beds and 34,011,386 hospital admissions in the year 2022.  Hence, hospitals held a significant share of the market in 2022.

Zika Virus Therapeutics Market Report Coverage

“Amongst regions, APAC is expected to witness a higher CAGR during the forecast period”

APAC is expected to grow with a high CAGR in the global zika virus therapeutics market in the forecast period. Several factors such as a surge in the development of a wide range of therapeutics for mosquito-borne diseases, enhanced accessibility, and diversified healthcare costs are driving the market’s growth during the forecast period. Further, the increase in incidences regarding mosquito-borne diseases is also having a positive impact on the market’s growth. There have been significant improvisations and enhancements in zika virus therapeutics in the region. Thus, APAC is expected to witness a higher CAGR during the forecast period.

REQUEST FOR CUSTOMIZATION

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.

Customization Options:

The global zika virus therapeutics market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

Frequently Asked Questions (FAQ)

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team

Research Methodology

Research Methodology for the Zika Virus Therapeutics Market Analysis (2023-2030)

Analyzing the historical market, estimating the current market, and forecasting the future market of the global zika virus therapeutics market were the three major steps undertaken to create and analyze the adoption of zika virus therapeutics in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global zika virus therapeutics market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the zika virus therapeutics market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the zika virus therapeutics market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as vaccine type, end user, and regions. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the zika virus therapeutics market. Further, we conducted factor analysis using dependent and independent variables such as vaccine type, end user, and regions of zika virus therapeutics. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the zika virus therapeutics market sector across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global zika virus therapeutics market, and market shares of the segments. All the required percentage shares split and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2030 00for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

• The industry’s market size, in terms of revenue (USD) and the adoption rate of the zika virus therapeutics market across the major markets domestically
• All percentage shares, splits, and breakdowns of market segments and sub-segments
• Key players in the global zika virus therapeutics market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global zika virus therapeutics market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of vaccine type, end user, and regions in the global zika virus therapeutics market.

The main objective of the Global Zika Virus Therapeutics Market Study

The current & future market trends of the global zika virus therapeutics market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:

• Analyze the current and forecast market size of the zika virus therapeutics market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
• Segments in the study include areas of vaccine type, end user, and regions
• Define and analyze the regulatory framework for the zika virus therapeutics industry.
• Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry.
• Analyze the current and forecast market size of the zika virus therapeutics market for the major region.
• Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World.
• Company profiles of the zika virus therapeutics market and the growth strategies adopted by the market players to sustain in the fast-growing market
• Deep dive regional level analysis of the industry

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team